New U.S. national estimate reveals 322,000 healthcare professionals sustain sharps injuries annually
“In 2012 The Association of Occupational Health Professionals in Healthcare (AOHP) commissioned a new Exposure Study of Occupational Practice (EXPO-S.T.O.P.) among its members to establish a nationally representative BE database and benchmark resource” Grimmond and Good (2013).
“More than half of SI from SED are due to non-activation of devices, and monitoring of activations is recommended. This paper outlines the findings of a sharps container (SC) contents audit conducted in Florida in September 2013” Grimmond (2014).
“Overall retention of training was excellent, and this supports earlier reports that patient-administered outpatient parenteral antibiotic therapy is as safe as nurse-administered therapy” Eaves et al (2014).
“Vancomycin-associated nephrotoxicity (VN) occurred in 26 of 155 (17%) patient episodes” Norton et al (2014).
“We undertook a retrospective study of 549 consecutive adult Out-Patient Antimicrobial Treatment (OPAT) episodes treated with intravenous teicoplanin” Matthews et al (2014).
“A significant proportion of patients with MRSA SSTI may be suitable for outpatient management with either oral therapy via OPAT, with the potential for significant reduction in healthcare costs” Seaton et al (2014).
“Non-availability of recommended test results to treating physicians for patients on OPAT is associated with increased readmissions during OPAT” Huck et al (2014).
“This work has shown how prospective data collection in the OPAT setting can yield valuable insights into the effectiveness and safety of the management of many conditions, such as osteoarticular infection and endocarditis, in a diverse range of populations and increasingly from different countries” MacKenzie et al (2014).
“This retrospective cohort study found a low incidence of VTE in OPAT patients, and does not support routine application of inpatient VTE prophylaxis algorithms to patients treated for infection in the community” Barr et al (2014).
“Patients prescribed OPAT are at risk for readmission. A subgroup of patients at especially high risk can be identified using easily obtainable clinical characteristics at the time of hospital discharge” Allison et al (2014).
“Patients receiving daptomycin at home have 60% fewer antimicrobial adverse events and require 80% fewer antimicrobial interventions than similar patients receiving vancomycin” Shrestha et al (2014).
“At our university-affiliated county teaching hospital with mandatory Infectious Diseases (ID) approval for all OPATcourses, we looked at clinical outcomes and cost savings of patients denied OPAT” Conant et al (2014).
“We report successful use of ertapenem delivered in a hospital-based OPAT unit for TRUSPBx prophylaxis” Shakil et al (2014).
“We conducted a retrospective cohort study of adult patients who received outpatient ertapenem therapy at our center between 2010 and 2013” Qureshi et al (2014).